The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of TP53 mutations in metastatic non-squamous non-small-cell lung cancer.
 
Laurent Mathiot
No Relationships to Disclose
 
Benoît Nigen
No Relationships to Disclose
 
Thomas Goronflot
No Relationships to Disclose
 
Sandrine Hiret
Consulting or Advisory Role - AstraZeneca; BMS; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Novartis; Roche
 
Ludovic Doucet
Consulting or Advisory Role - Amgen; AstraZeneca; Takeda
 
Elvire Pons-Tostivint
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Daichii; Daichii; Ipsen; Janssen Oncology; MSD Oncology; Novartis; SERVIER
Consulting or Advisory Role - AMGEN; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; SERVIER
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Marc G. Denis
Consulting or Advisory Role - AstraZeneca
Research Funding - Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Molecular Diagnostics; Takeda
 
Guillaume Herbreteau
No Relationships to Disclose
 
Judith Raimbourg
No Relationships to Disclose